Recent Finacing
Recent Raise
Aurion Biotech develops a cultured donor-derived corneal endothelial cell therapy for corneal edema, producing single-donor batches that can treat 100+ eyes and pursuing J-NDA and IND submissions.
Focus Areas
Recent Investors
Total Raised
Funding round
Investors
See the team members at Aurion Biotechnologies.
